KNTPF (Kintor Pharmaceutical) Days Payable : 726.94 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Kintor Pharmaceutical Days Payable?

Kintor Pharmaceutical's average Accounts Payable for the six months ended in Dec. 2024 was $5.94 Mil. Kintor Pharmaceutical's Cost of Goods Sold for the six months ended in Dec. 2024 was $1.49 Mil. Hence, Kintor Pharmaceutical's Days Payable for the six months ended in Dec. 2024 was 726.94.

The historical rank and industry rank for Kintor Pharmaceutical's Days Payable or its related term are showing as below:

KNTPF' s Days Payable Range Over the Past 10 Years
Min: 641.28 Med: 2050.74 Max: 9684.85
Current: 1961.58

During the past 7 years, Kintor Pharmaceutical's highest Days Payable was 9684.85. The lowest was 641.28. And the median was 2050.74.

KNTPF's Days Payable is ranked better than
89.93% of 705 companies
in the Biotechnology industry
Industry Median: 122.62 vs KNTPF: 1961.58

Kintor Pharmaceutical's Days Payable increased from Dec. 2023 (322.69) to Dec. 2024 (726.94). It may suggest that Kintor Pharmaceutical delayed paying its suppliers.

Kintor Pharmaceutical Days Payable Historical Data

The historical data trend for Kintor Pharmaceutical's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kintor Pharmaceutical Days Payable Chart

Kintor Pharmaceutical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

642.39

2,043.67

Kintor Pharmaceutical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Payable	Get a 7-Day Free Trial								-	-	322.69	-	726.94

Competitive Comparison of Kintor Pharmaceutical's Days Payable

For the Biotechnology subindustry, Kintor Pharmaceutical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kintor Pharmaceutical's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kintor Pharmaceutical's Days Payable distribution charts can be found below:

* The bar in red indicates where Kintor Pharmaceutical's Days Payable falls into.

Save Embed

;

Save Embed

;

Kintor Pharmaceutical Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Kintor Pharmaceutical's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (9.564	+	5.408)	/	2 )	/	1.337	*	365
=	7.486					/	1.337	*	365
=	2,043.67

Kintor Pharmaceutical's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (6.478	+	5.408)	/	2 )	/	1.492	*	365 / 2
=	5.943					/	1.492	*	365 / 2
=	726.94

Kintor Pharmaceutical Days Payable Related Terms

Thank you for viewing the detailed overview of Kintor Pharmaceutical's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Kintor Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kintor Pharmaceutical Ltd (OTCPK:KNTPF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

09939:Hong Kong

Address

No. 20 Songbei Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215123

Website

https://www.kintor.com.cn

Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China focused on the proprietary R&D of drugs for cancers and other AR-related diseases. The company's drug candidate, Pruxelutamide, is a drug undergoing phase III clinical trials in China and phase III clinical trials in the United States for mCRPC as well as clinical trials for breast cancer. Its pipeline of seven drug candidates includes Pruxelutamide (GT0918), Pyrilutamide (KX-826), ALK-1 (GT90001), Detorsertib (GT0486), Hedgehog/SMO Inhibitor (GT1708F), PD-L1/TGF-B (GT90008), and AR-PROTAC Compound (GT20029). The company operates in a single segment focusing on the research and development of medical products.